A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants
Clinical trial NCT02543567 · COMPLETED
Trial details
- NCT number
- NCT02543567
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-21
- Primary completion
- 2016-06-07
- Enrollment
- 525
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.